Facilitating Rapid Naltrexone Initiation (NCT03345173)
Glutamatergic Modulation to Facilitate Naltrexone Initiation: A Randomized, Controlled Trial
๐ฉบ Plain-English Summary (8th-Grade Level)
The incidence of opioid use disorders (OUDs) has increased to near-epidemic proportions. While maintenance with long-acting opioids such as methadone or buprenorphine represents an effective treatment strategy, it may be unacceptable to many individuals. As a result, long-acting injectable naltrexone (XR-NTX), an antagonist medication that blocks the effects of opioids for at least 4 weeks, is now indicated for relapse prevention following detoxification. This randomized, controlled trial aims to test the efficacy of a glutamate modulator at facilitating a rapid non-opioid based naltrexone induction.
Who can join: Review the eligibility criteria below.
Location: New York State Psychiatric Institute โ New York, New York
Age range: 18 Years to 70 Years
๐งช Interventions in This Study
๐ "Do I Qualify?" โ 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria โ
๐ All Participating Trial Locations (1 Sites)
- New York State Psychiatric Institute โ New York, New York
๐ฐ Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Opioid Dependence
- VK4-116 Phase I Study With Food-Effect โ Overland Park, Kansas
- The MOUD Plus Pilot: Counseling and Peer Support to Support Retention for Medically Complex Patients With Opioid Use Disorder Seen In Primary Care โ Portland, Oregon
- Standardized Natural Psilocybin-assisted Psychotherapy for Tapering of Opioid Medication โ Kelowna, British Columbia
Explore by condition: All Opioid Dependence clinical trials
๐ก How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.